Templeton AC - Search Results

1

Molecular Mechanism of P53 Peptide Permeation through Lipid Membranes from Solid-State NMR Spectroscopy and Molecular Dynamics Simulations.

Li M, Li J, Lu X, Schroder R, Chandramohan A, Wuelfing WP, Templeton AC, Xu W, Gindy M, Kesisoglou F, Ling J, Sawyer T, Verma CS, Partridge AW, Su Y. Li M, et al. Among authors: templeton ac. J Am Chem Soc. 2024 Aug 21;146(33):23075-23091. doi: 10.1021/jacs.4c04230. Epub 2024 Aug 7. J Am Chem Soc. 2024. PMID: 39110018

2

Monolayer-protected cluster molecules.

Templeton AC, Wuelfing WP, Murray RW. Templeton AC, et al. Acc Chem Res. 2000 Jan;33(1):27-36. doi: 10.1021/ar9602664. Acc Chem Res. 2000. PMID: 10639073

3

Polysorbate 80 UV/vis spectral and chromatographic characteristics--defining boundary conditions for use of the surfactant in dissolution analysis.

Wuelfing WP, Kosuda K, Templeton AC, Harman A, Mowery MD, Reed RA. Wuelfing WP, et al. Among authors: templeton ac. J Pharm Biomed Anal. 2006 Jun 7;41(3):774-82. doi: 10.1016/j.jpba.2006.01.020. Epub 2006 Mar 6. J Pharm Biomed Anal. 2006. PMID: 16517110

4

Effect of added alkalizer and surfactant on dissolution and absorption of the potassium salt of a weakly basic poorly water-soluble drug.

Mahjour M, Kesisoglou F, Cruanes M, Xu W, Zhang D, Maguire TJ, Rosen LA, Templeton AC, Kress MH. Mahjour M, et al. Among authors: templeton ac. J Pharm Sci. 2014 Jun;103(6):1811-8. doi: 10.1002/jps.23985. Epub 2014 Apr 30. J Pharm Sci. 2014. PMID: 24788413

5

Preclinical dose number and its application in understanding drug absorption risk and formulation design for preclinical species.

Wuelfing WP, Daublain P, Kesisoglou F, Templeton A, McGregor C. Wuelfing WP, et al. Mol Pharm. 2015 Apr 6;12(4):1031-9. doi: 10.1021/mp500504q. Epub 2015 Mar 11. Mol Pharm. 2015. PMID: 25671350

6

New and Evolving Techniques for the Characterization of Peptide Therapeutics.

D'Addio SM, Bothe JR, Neri C, Walsh PL, Zhang J, Pierson E, Mao Y, Gindy M, Leone A, Templeton AC. D'Addio SM, et al. Among authors: templeton ac. J Pharm Sci. 2016 Oct;105(10):2989-3006. doi: 10.1016/j.xphs.2016.06.011. Epub 2016 Aug 4. J Pharm Sci. 2016. PMID: 27499338 Review.

7

In-Use Photostability Practice and Regulatory Evaluation for Pharmaceutical Products in an Age of Light-Emitting Diode Light Sources.

Allain LR, Pierce BC, Wuelfing WP, Templeton AC, Helmy R. Allain LR, et al. Among authors: templeton ac. J Pharm Sci. 2019 Mar;108(3):1172-1176. doi: 10.1016/j.xphs.2018.10.003. Epub 2018 Oct 10. J Pharm Sci. 2019. PMID: 30315811

8

Molecular Mechanism of Crystalline-to-Amorphous Conversion of Pharmaceutical Solids from ¹⁹F Magic Angle Spinning NMR.

Lu X, Huang C, Li M, Skomski D, Xu W, Yu L, Byrn SR, Templeton AC, Su Y. Lu X, et al. Among authors: templeton ac. J Phys Chem B. 2020 Jun 25;124(25):5271-5283. doi: 10.1021/acs.jpcb.0c02131. Epub 2020 May 19. J Phys Chem B. 2020. PMID: 32378905

9

Atomic-Level Drug Substance and Polymer Interaction in Posaconazole Amorphous Solid Dispersion from Solid-State NMR.

Lu X, Li M, Huang C, Lowinger MB, Xu W, Yu L, Byrn SR, Templeton AC, Su Y. Lu X, et al. Among authors: templeton ac. Mol Pharm. 2020 Jul 6;17(7):2585-2598. doi: 10.1021/acs.molpharmaceut.0c00268. Epub 2020 May 28. Mol Pharm. 2020. PMID: 32401529

10

Molecular packing of pharmaceuticals analyzed with paramagnetic relaxation enhancement and ultrafast magic angle pinning NMR.

Lu X , Tsutsumi Y , Huang C , Xu W , Byrn SR , Templeton AC , Buevich AV , Amoureux JP , Su Y . Lu X , et al. Among authors: templeton ac. Phys Chem Chem Phys. 2020 Jun 21;22(23):13160-13170. doi: 10.1039/d0cp02049d. Epub 2020 Jun 4. Phys Chem Chem Phys. 2020. PMID: 32495810

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters